Obeso JA - Search Results

1

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Marin C, et al. Among authors: obeso ja. Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008. Exp Neurol. 2005. PMID: 15698633

2

Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

Marin C, Rodriguez-Oroz MC, Obeso JA. Marin C, et al. Among authors: obeso ja. Exp Neurol. 2006 Feb;197(2):269-74. doi: 10.1016/j.expneurol.2005.11.002. Epub 2005 Dec 22. Exp Neurol. 2006. PMID: 16375892 Review. No abstract available.

3

Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Marin C, et al. Among authors: obeso ja. Eur J Neurosci. 2007 Jan;25(1):259-69. doi: 10.1111/j.1460-9568.2006.05265.x. Eur J Neurosci. 2007. PMID: 17241287

4

Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.

Marin C, Aguilar E, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Marin C, et al. Among authors: obeso ja. Neurobiol Dis. 2008 Dec;32(3):340-8. doi: 10.1016/j.nbd.2008.07.019. Epub 2008 Aug 5. Neurobiol Dis. 2008. PMID: 18722529 Free article.

5

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.

Marin C, Aguilar E, Rodríguez-Oroz MC, Bartoszyk GD, Obeso JA. Marin C, et al. Among authors: obeso ja. Psychopharmacology (Berl). 2009 Jun;204(2):241-50. doi: 10.1007/s00213-008-1452-9. Epub 2009 Jan 22. Psychopharmacology (Berl). 2009. PMID: 19159919

6

Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Marin C, et al. Among authors: obeso ja. Eur J Neurosci. 2009 Sep;30(5):823-32. doi: 10.1111/j.1460-9568.2009.06877.x. Epub 2009 Aug 27. Eur J Neurosci. 2009. PMID: 19712101

7

Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment.

Marin C, Obeso JA. Marin C, et al. Among authors: obeso ja. Int Rev Neurobiol. 2010;95:191-205. doi: 10.1016/B978-0-12-381326-8.00008-9. Int Rev Neurobiol. 2010. PMID: 21095463 Review.

8

Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.

Marin C, Bonastre M, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Marin C, et al. Among authors: obeso ja. Exp Neurol. 2013 Dec;250:304-12. doi: 10.1016/j.expneurol.2013.10.006. Epub 2013 Oct 18. Exp Neurol. 2013. PMID: 24140562

9

The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits.

Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodriguez-Diaz M. Obeso JA, et al. Neurology. 2004 Jan 13;62(1 Suppl 1):S17-30. doi: 10.1212/wnl.62.1_suppl_1.s17. Neurology. 2004. PMID: 14718677 Review.

10

[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].

Castro A, Valldeoriola F, Linazasoro G, Rodriguez-Oroz MC, Stochi F, Marin C, Rodriguez M, Vaamonde J, Jenner P, Alvarez L, Pavon N, Macias R, Luquin MR, Hernandez B, Grandas F, Gimenez-Roldan S, Tolosa E, Obeso JA. Castro A, et al. Among authors: obeso ja. Neurologia. 2005 May;20(4):180-8. Neurologia. 2005. PMID: 15891947 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters